首页> 美国卫生研究院文献>other >In Vitro Assessment of the Probiotic Potential of Lactococcus lactis LMG 7930 against Ruminant Mastitis-Causing Pathogens
【2h】

In Vitro Assessment of the Probiotic Potential of Lactococcus lactis LMG 7930 against Ruminant Mastitis-Causing Pathogens

机译:乳酸乳球菌LMG 7930对反刍乳腺炎致病菌的益生菌潜力的体外评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mastitis in dairy ruminants is considered to be the most expensive disease to farmers worldwide. Recently, the intramammary infusion of lactic acid bacteria has emerged as a potential new alternative to antibiotics for preventing and treating bovine mastitis. In this study we have investigated in vitro the probiotic potential of Lactococcus lactis LMG 7930, a food-grade and nisin-producing strain, against mastitis-causing pathogens. We have characterized its carbohydrate fermentation and antibiotic susceptibility profiles, cell surface properties and antimicrobial activity, as well as its capabilities to adhere to and inhibit the invasion of pathogens into the bovine mammary epithelial cell line BME-UV1d. We found that L. lactis LMG 7930 was sensitive to tested drugs, according to the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), and showed an improved carbohydrate fermentation capacity compared to starter strains. Moreover, the strain exhibited antagonistic properties towards many of the pathogens tested. It presented medium surface hydrophobicity, a low basic property and no electron acceptor capability. It showed low auto-aggregation and no co-aggregation abilities towards any of the tested pathogens. The strain was one of the most adhesive to bovine mammary epithelial cells among tested bacteria, but its internalisation was low. The strain did not affect significantly pathogen invasion; however, a trend to decrease internalization of some pathogens tested was observed. In conclusion, our results suggest that this strain might be a promising candidate for the development of new strategies of mastitis control in ruminants. Future investigations are needed to evaluate its safety and efficacy under field conditions.
机译:奶牛反刍动物中的乳腺炎被认为是全世界农民最昂贵的疾病。近来,乳酸菌的乳房内输注已经成为预防和治疗牛乳腺炎的抗生素的潜在新替代品。在这项研究中,我们研究了乳酸乳球菌LMG 7930(一种食品级产乳链菌肽的菌株)对引起乳腺炎的病原体的益生菌潜力。我们已经表征了其碳水化合物的发酵和抗生素敏感性概况,细胞表面特性和抗菌活性,以及​​其粘附和抑制病原体侵入牛乳腺上皮细胞系BME-UV1d的能力。根据EFSA动物饲料中使用的添加剂和产品或物质小组(FEEDAP)的数据,我们发现乳酸乳球菌LMG 7930对测试的药物敏感,并且与发酵菌株相比,它显示出更高的碳水化合物发酵能力。此外,该菌株对许多测试的病原体表现出拮抗特性。它表现出中等的表面疏水性,低的基本性能并且没有电子受体能力。它显示出低的自动聚集性,并且对任何测试的病原体均无共聚集能力。该菌株是测试细菌中与牛乳腺上皮细胞最粘连的菌株之一,但其内在化程度很低。该菌株没有显着影响病原体的入侵。但是,观察到了一些测试病原体内部化程度降低的趋势。总之,我们的结果表明,该菌株可能是开发反刍动物乳腺炎控制新策略的有希望的候选者。需要进一步的研究以评估其在野外条件下的安全性和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号